Cullinan Oncology LLC

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-77
-76
-77
-76
EBITDA
-75,798
-54,920
-54,971
-48,779
EBIT
-75,875
-54,996
-55,048
-48,855
Net Income
-70,055
-48,501
-47,647
-40,560
Net Change In Cash
0
0
0
0
Free Cash Flow
-57,609
-43,155
-36,626
-34,139
Cash
72,820
76,655
83,005
102,085
Basic Shares
59,015
58,905
58,580
58,337

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$18,943
Gross Profit
-306
-310
-93
18,943
EBITDA
-167,152
-190,339
151,409
-67,901
EBIT
-167,458
-190,649
151,316
-67,954
Net Income
-167,383
-153,162
111,214
-65,040
Net Change In Cash
0
0
0
18,943
Cost of Revenue
96,378
-108,424
Free Cash Flow
-145,303
-134,483
-127,797
-44,022
Cash
83,005
98,434
156,152
59,774
Basic Shares
53,771
41,550
46,640
44,292

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$1.07
2025-03-31
-$0.74
2024-12-31
-$0.73